Without proper treatment, half of the 370,000 children newly infected with HIV last year will die before they reach their second birthday. But very few medicines are designed and adapted specifically for children, and are affordable and practical to use in the places where they live. The Drugs for Neglected Diseases initiative (DNDi) recently announced a new project to help develop appropriate HIV drugs for children.
Listen to this podcast where Rachel Cohen, DNDi's Regional Executive Director in North America, explains more.
Previously Cohen served as Head of Mission for MSF in South Africa and Lesotho, where she oversaw numerous medical programmes, primarily focused on HIV/AIDS and tuberculosis treatment in rural and peri-urban settings, primary health care for Zimbabwean refugees, asylum-seekers, and migrants, and emergency care for survivors of sexual violence.
For more information on the Drugs For Neglected Diseases initiative, go to www.DNDi.org .